Effect of an intervention on quality indicators for improving the treatment of hyperglycemia in patients hospitalized in noncritical areas

OBJECTIVESWe evaluated the effect of an intervention on certain quality indicators employed for improving the treatment of hospital hyperglycemia. MATERIAL AND METHODSA multicenter cross-sectional study was conducted on patients with hyperglycemia hospitalized in the internal medicine departments of...

Full description

Saved in:
Bibliographic Details
Published in:Revista clínica espanõla (English edition) 2016-10, Vol.216 (7), p.352-360
Main Authors: Ena, J, Gómez-Huelgas, R, Zapatero-Gaviria, A, Vázquez-Rodriguez, P, González-Becerra, C, Romero-Sánchez, M, Igúzquiza-Pellejero, M J, Artero-Mora, A, Varela-Aguilar, J M
Format: Article
Language:eng ; spa
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVESWe evaluated the effect of an intervention on certain quality indicators employed for improving the treatment of hospital hyperglycemia. MATERIAL AND METHODSA multicenter cross-sectional study was conducted on patients with hyperglycemia hospitalized in the internal medicine departments of 44 hospitals evaluated in 2 time periods: 2014 (baseline period) and 2015 (postintervention period). The intervention consisted of the dissemination of the indicators obtained in 2014 and the objectives for improvement. As indicators, we assessed the frequency of glucose monitoring adapted to the patient's dietary intake or medication, the use of basal-bolus or basal-bolus-correction insulin therapy as the preferred control method of hyperglycemia and the recent availability of HbA1c prior to hospital discharge. RESULTSA total of 506 and 562 patients were assessed in 2014 and 2015, respectively. The results of the indicators in the baseline and postintervention periods were as follows: blood glucose monitoring adapted to the dietary intake or the medication (71.5 vs. 74.1%, P=.33), use of insulin in basal-correction regimen (32 vs. 32.6%, P=.61) or basal-bolo-correction (20.7 vs. 24, P=.20) and recent HbA1c value (54.1 vs. 66.3%, P
ISSN:2254-8874
DOI:10.1016/j.rce.2016.05.006